According to the new market research report, "Cell Isolation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End-User (Hospitals, Biotechnology) - Global Forecast to 2025" The global Cell Isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9 billion in 2020, at a 16.8% CAGR.
Global Industry Growth Boosting Factors:
The increasing government funding for cell-based research, the increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine are the major factors driving the cell isolation markets growth. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the cell isolation market.
This study involved four major activities in estimating the current size of the cell isolation market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Download PDF [email protected]
Driver: Increasing government funding for cell based research
Researchers utilize isolated cells to understand their biology and develop new cell therapies and other cell-based treatments. Various government bodies across the globe have increased their support for the growth of such research activities, owing to its importance. For instance, in January 2016, the Federal Government of Canada granted USD 20 million to the Centre for Commercialization of Regenerative Medicine. This grant will be utilized for establishing a stem-cell therapy development facility in Toronto, Canada. In addition, NIH funding for the development of cell therapies has increased significantly over the last few years. This, in turn, is stimulating the demand for equipment, media, reagents, and accessories used in cell isolation research.
Opportunity: Emerging Markets
Emerging countries, especially in the Asia Pacific region, are expected to become a focal point for growth in the cell isolation market. The increasing investments in cell biology research and the growing presence of market players in emerging regions are the major factors responsible for the high growth of the cell isolation market in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D in order to introduce new drugs in the market. Dr. Reddy’s Laboratories, one of the major players in the Indian pharmaceutical market, spent USD 297 million on R&D in 2017. Such investments are expected to increase the demand for cell isolation products in the country in the coming years.
Also, in May 2017, India’s Cabinet Committee on Economic Affairs announced plans to invest ~USD 250 million-half of it to be funded by the World Bank-through 2023 toward industry-academic collaborations to develop vaccines, therapeutics, and medical devices. The program is one of the biggest steps to achieving India’s long-stated goal of growing its biotechnology industry to USD 100 billion by 2025. Due to the increasing R&D activities in the pharmaceutical and biotechnology industries, the adoption of several advanced equipment and methodologies is expected to increase in the country with the aim of increasing productivity.
Restraint: cost of cell- based research
Cell biology involves extensive research on the development of new therapies such as stem cell and gene therapies. The instruments, reagents, and other products associated with this research are required to be of high quality in order to obtain accurate results. Owing to the need to maintain high-quality standards and comply with guidelines set up by regulatory authorities, the cost of research in cell biology is high. In addition, the success rate of cell-based research is very limited, and most cell therapy trials have a low success rate.
Request Sample [email protected]
In 2019, biotechnology and biopharmaceutical companies segment accounted for the largest share in the market, by end user
The cell isolation market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The large share of this end-user segment can be attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally.